ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,000 | +10.5% | 178 | -55.3% | 0.00% | – |
| Q2 2022 | $19,000 | -32.1% | 398 | 0.0% | 0.00% | – |
| Q1 2022 | $28,000 | -6.7% | 398 | 0.0% | 0.00% | – |
| Q4 2021 | $30,000 | +30.4% | 398 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | +27.8% | 398 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | -10.0% | 398 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | -4.8% | 398 | -20.9% | 0.00% | – |
| Q4 2020 | $21,000 | -8.7% | 503 | 0.0% | 0.00% | – |
| Q3 2020 | $23,000 | -8.0% | 503 | 0.0% | 0.00% | – |
| Q2 2020 | $25,000 | -84.2% | 503 | -81.4% | 0.00% | – |
| Q4 2017 | $158,000 | +464.3% | 2,700 | +350.0% | 0.00% | – |
| Q3 2017 | $28,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |